The Joint Corp. (NASDAQ:JYNT – Get Rating) has earned a consensus rating of “Hold” from the nine ratings firms that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $91.40.
A number of equities analysts have commented on the stock. StockNews.com lowered shares of Joint from a “hold” rating to a “sell” rating in a report on Saturday, April 2nd. Lake Street Capital dropped their target price on shares of Joint from $150.00 to $100.00 in a research report on Friday, February 25th. B. Riley dropped their target price on shares of Joint from $125.00 to $88.00 in a research report on Friday, February 25th. Zacks Investment Research downgraded shares of Joint from a “buy” rating to a “sell” rating in a research report on Tuesday, March 1st. Finally, Craig Hallum dropped their target price on shares of Joint from $117.00 to $90.00 in a research report on Monday, January 24th.
In other news, CEO Peter D. Holt bought 1,500 shares of the company’s stock in a transaction that occurred on Wednesday, March 16th. The shares were purchased at an average price of $33.24 per share, for a total transaction of $49,860.00. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jake Singleton bought 1,515 shares of the company’s stock in a transaction that occurred on Wednesday, March 16th. The stock was purchased at an average price of $33.00 per share, for a total transaction of $49,995.00. The disclosure for this purchase can be found here. 4.60% of the stock is owned by corporate insiders.
JYNT stock traded up $0.81 during midday trading on Wednesday, hitting $35.10. The stock had a trading volume of 249,182 shares, compared to its average volume of 258,598. The firm has a market cap of $505.90 million, a PE ratio of 73.13 and a beta of 1.27. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.25 and a quick ratio of 1.25. Joint has a 12-month low of $29.84 and a 12-month high of $111.06. The company’s 50-day moving average price is $40.31 and its 200 day moving average price is $62.45.
Joint (NASDAQ:JYNT – Get Rating) last announced its quarterly earnings results on Thursday, February 24th. The company reported $0.01 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.07). The company had revenue of $22.43 million during the quarter, compared to analyst estimates of $22.21 million. Joint had a net margin of 8.82% and a return on equity of 26.30%. During the same quarter last year, the business earned $0.12 EPS. As a group, sell-side analysts anticipate that Joint will post 0.33 EPS for the current year.
Joint Company Profile (Get Rating)
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States.
- Get a free copy of the StockNews.com research report on Joint (JYNT)
- OrganiGram’s Turnaround Begins To Blossom
- Three Dividend Stocks With Growth Potential
- Exelon Stock Still Has Extraordinary Upside
- Ross Stores On The Verge Of Major Rally
- Insiders Are Selling Palo Alto Networks
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.